Maravai LifeSciences
Deb Barbara joined Maravai in April 2022. Ms. Barbara has over 30 years of experience in a variety of business development roles, most recently as Senior Director/General Manager, of Nucleic Acid Therapeutics for Thermo Fisher Scientific. Prior to that, she was Vice President, Business Development at Strategic Diagnostics (SDIX). Prior to SDIX, Ms. Barbara was Vice President, Business Development and Licensing at Gene Logic/Ore Pharmaceuticals. Prior to Ore Pharmaceuticals, she spent seven years at Johns Hopkins University with her last role as Senior Director, Business/Technology Development, and 11 years at Amersham Life Science in progressive account management roles. Ms. Barbara holds an MBA from Loyola University Maryland and a B.S. in Biochemistry and Molecular Biology from the University of Maryland Baltimore County.
This person is not in any offices
Maravai LifeSciences
Maravai LifeSciences enables the miracles of science and improves the human condition through its portfolio of market-leading companies and proprietary technologies. Biomedical innovation is dependent on a reliable supply of reagents in the fields of nucleic acid production, biologics safety testing, and protein detection.